Although initial trials with high-dose anti-tumor necrosis factor alpha agents were associated with worsening HF [18,19], some recent studies do not show a detrimental effect of this therapy on cardiac function in rheumatoid arthritis patients [20]. The gene discussed is TNF; the disease is hydrops fetalis.